A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer.

J Adv Res · 2020 · PMC7190757 · PMID 32368355

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

highly significantP < 0.05actually significant

The log-rank test and Kaplan–Meier plots of OS and PFS showed highly significant differences ( P < 0.05) between the active and control arms.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.